SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    George Konstantakopoulos, Stefanos Dimitrakopoulos, Panayiota G Michalopoulou, Drugs under early investigation for the treatment of bipolar disorder, Expert Opinion on Investigational Drugs, 2015, 24, 4, 477

    CrossRef

  2. 2
    Francesca Demontis, Marcella Falconi, Desirèe Canu, Gino Serra, Memantine prevents “bipolar-like” behavior induced by chronic treatment with imipramine in rats, European Journal of Pharmacology, 2015, 752, 49

    CrossRef

  3. 3
    Mark J. Niciu, Ioline D. Henter, David A. Luckenbaugh, Carlos A. Zarate, Dennis S. Charney, Glutamate Receptor Antagonists as Fast-Acting Therapeutic Alternatives for the Treatment of Depression: Ketamine and Other Compounds, Annual Review of Pharmacology and Toxicology, 2014, 54, 1, 119

    CrossRef

  4. 4
    Emily KL Sandlin, Yonglin Gao, Rif S El-Mallakh, Pharmacotherapy of bipolar disorder: current status and emerging options, Clinical Practice, 2014, 11, 1, 39

    CrossRef

  5. 5
    Mehdi Ghasemi, Cristy Phillips, Ludwig Trillo, Zurine De Miguel, Devsmita Das, Ahmad Salehi, The role of NMDA receptors in the pathophysiology and treatment of mood disorders, Neuroscience & Biobehavioral Reviews, 2014, 47, 336

    CrossRef

  6. 6
    Dominik Strzelecki, Agnieszka Tabaszewska, Zbigniew Barszcz, Olga Józefowicz, Paweł Kropiwnicki, Jolanta Rabe-Jabłońska, A 10-Week Memantine Treatment in Bipolar Depression: A Case Report. Focus on Depressive Symptomatology, Cognitive Parameters and Quality of Life, Psychiatry Investigation, 2013, 10, 4, 421

    CrossRef

  7. 7
    Brian Lord, Cindy Wintmolders, Xavier Langlois, Leslie Nguyen, Tim Lovenberg, Pascal Bonaventure, Comparison of the ex vivo receptor occupancy profile of ketamine to several NMDA receptor antagonists in mouse hippocampus, European Journal of Pharmacology, 2013, 715, 1-3, 21

    CrossRef

  8. 8
    John H. Krystal, Gerard Sanacora, Ronald S. Duman, Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond, Biological Psychiatry, 2013, 73, 12, 1133

    CrossRef

  9. 9
    Konstantinos N. Fountoulakis, Siegfried Kasper, Ole Andreassen, Pierre Blier, Ahmed Okasha, Emanuel Severus, Marcio Versiani, Rajiv Tandon, Hans-Jürgen Möller, Eduard Vieta, Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry, European Archives of Psychiatry and Clinical Neuroscience, 2012, 262, S1, 1

    CrossRef

  10. 10
    Daniel C. Mathews, Ioline D. Henter, Carlos A. Zarate, Targeting the Glutamatergic System to Treat Major Depressive Disorder, Drugs, 2012, 72, 10, 1313

    CrossRef

  11. 11
    Gabriele Sani, Giulia Serra, Giorgio D. Kotzalidis, Silvia Romano, Stefano M. Tamorri, Giovanni Manfredi, Matteo Caloro, C. Ludovica Telesforo, Saverio S. Caltagirone, Isabella Panaccione, Alessio Simonetti, Francesca Demontis, Gino Serra, Paolo Girardi, The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias, CNS Drugs, 2012, 26, 8, 663

    CrossRef